Niagen Bioscience (NAGE) closed at $2.50 on October 29, 2026, down 1.6% from the previous close, on volume of 330,820 shares (30-day average 518,363).
Data as of October 29, 2026.
29-Oct-2026
Niagen Bioscience Launches Niagen Plus Liquid At-Home Injections to Support Telehealth Expansion
Business Wire (Thu, 22-Oct 8:38 AM ET)
Business Wire (Tue, 20-Oct 8:32 AM ET)
Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Business Wire (Thu, 15-Oct 8:32 AM ET)
Business Wire (Thu, 8-Oct 8:32 AM ET)
Niagen Bioscience to Present at LD Micro 20th Annual Main Event
Business Wire (Tue, 6-Oct 8:32 AM ET)
Business Wire (Thu, 1-Oct 8:32 AM ET)
Business Wire (Wed, 30-Sep 8:32 AM ET)
Business Wire (Mon, 21-Sep 8:32 AM ET)
Business Wire (Thu, 17-Sep 8:32 AM ET)
Niagen Bioscience to Present at Canaccord Genuity's Well Summit
Business Wire (Thu, 10-Sep 8:32 AM ET)
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Niagen Bioscience trades on the NASDAQ stock market under the symbol NAGE.
As of October 29, 2026, NAGE stock price declined to $2.50 with 330,820 million shares trading.
NAGE has a beta of 1.04, meaning it tends to be more sensitive to market movements. NAGE has a correlation of 0.11 to the broad based SPY ETF.
NAGE has a market cap of $199.11 million. This is considered a Micro Cap stock.
Last quarter Niagen Bioscience reported $30 million in Revenue and $.01 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.01.
The top ETF exchange traded funds that NAGE belongs to (by Net Assets): VTI, IWM, VXF, VDC, IWO.
NAGE has underperformed the market in the last year with a price return of -65.6% while the SPY ETF gained +13.1%. NAGE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -24.0% and -1.2%, respectively, while the SPY returned +4.1% and 0.0%, respectively.
NAGE support price is $2.47 and resistance is $2.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NAGE shares will trade within this expected range on the day.
